Hangzhou DAC Biotechnology Co., Ltd.
PrivateLast Round
Strategic
Jun 1, 2022
Est. Valuation
$52.25M
Total Funding Raised
$322.77M
Company Overview
Hangzhou DAC Biotechnology Co., Ltd. is a biopharmaceutical company that specializes in the research, development, and production of monoclonal antibody-drug conjugates (ADCs) for the treatment of advanced cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hangzhou DAC Biotechnology Co., Ltd. Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Hangzhou DAC Biotechnology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Jun 1, 2022 | ||||
| Series C | May 10, 2021 | ||||
| Series C | Mar 1, 2021 | ||||
| Series B | Sep 1, 2019 | ||||
| Series A | May 1, 2017 | ||||
Pre Seed | Nov 27, 2015 |
Hangzhou DAC Biotechnology Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CPE (CPE Yuanfeng) | Series C |
| 中信金石投资有限公司 | Series C |
| ZJKF Capital Management | Pre Seed |
| Hillhouse Investment | Series C |
| CITIC Securities Company Limited | Series C |
| CITIC Securities | Series C |
| China International Capital Corporation | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 1, 2022
Led by Johnson & Johnson Innovation - JJDC, Inc.
- May 10, 2021
$156M round led by CDG Capital and Chenling Capital.
Hangzhou DAC Biotechnology Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Hangzhou DAC Biotechnology Co., Ltd.'s valuation, stock price, and market status.